Abstract: An antibody with an altered function, e.g. altered affinity for an effector ligand such as Fc receptor (FcR) on a cell or the C1 component of complement is produced by replacing at least one amino acid residue in the constant portion of the antibody with a different residue.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
April 29, 1997
Assignee:
Scotgen Biopharmaceuticals Incorporated
Inventors:
Gregory P. Winter, Alexander R. Duncan, Dennis R. Burton